Biological properties of proteins of the macroglobulin family and their role in the ovarian neoplastic process

Bazhenova L.G.

doi:https://doi.org/

Close metadata

Recommended articles:

Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33

Reduction of cytoskeleton gene expression in tumor cells during lentivirus transduction. Molecular Genetics, Microbiology and Virology. 2025;(1):30-37

Comparative analysis of morphometric and histological characteristics of HPV-associated and HPV-independent vulvar squamous cell carcinoma. Russian Journal of Archive of Pathology. 2025;(3):26-32

Heterogeneity of ALDH1, CD133 and CD34 expression in cancer stem cells of lung adenocarcinoma. Russian Journal of Archive of Pathology. 2025;(5):36-45

Abstract:

The paper presents the results of scientific publications by both Russian and foreign scientists and those of the author's studies of the biological properties of proteins of the macroglobulin family and their role in the development of an ovarian neoplastic process. It is suggested that immunosuppression accompanying tumor growth might be caused by the switch phenomenon of the synthesis of macroglobulins from α2-macroglobulin to pregnancy-associated α2-glycoprotein (PAG). The level of the latter in the ovarian malignancy cells has been found to be considerably dominant over that in the stroma. The predominance of a tumor cell component is likely to be accompanied by the higher PAG secretion by a growing tumor, which creates favorable conditions for the progression of ovarian cancer.

Keywords:

ovarian cancer

the biological properties of α2-macroglobulin and α2-glycoprotein

carcinogenesis

Authors:

Bazhenova L.G.

Kafedra akusherstva i ginekologii

Close metadata

References:

Bazhenova L.G., Zorina V.N.. Promzeleva N.V. i dr. Belki semeistva makroglobulinov (MG, ABG), immunoglobulin G i kompleksy MG-IgG v krovi bol'nykh s opukholyami i opukholevidnymi obrazovaniyami yaichnikov. Ros vestn akush-gin 2005; 4: 11-15.
Bazhenova L.G., Zorin N.A.. Durev V.N. i dr. Raspredelenie belkov semeistva makroglobulinov v tkanyakh dobrokachestvennykh, pogranichnykh i zlokachestvennykh seroznykh opukholei yaichnikov. Ros vestn akush-gin 2006; 2: 9-12.
Bazhenova L.G. Differentsial'naya diagnostika opukholei i opukholevidnykh obrazovanii yaichnikov: Avtoref. dis. … d-ra med. nauk. M 2007; 46.
Gederim M.N. Faktory prognoza pri nachal'nykh stadiyakh raka yaichnikov: Avtoref. dis. … kand. med. nauk. St-Peterburg 2000; 24.
Zorin N.A., Zorina V.N., Zorina R.M. Universal'nyi modulyator tsitokinov α2-makroglobulin. Immunologiya 2004; 5: 302-303.
Zorin N.A., Zorina V.N., Zorina R.M. Rol' al'fa-2-makroglobulina pri onkologicheskikh zabolevaniyakh. Vopr onkol 2004; 50: 5: 515-519.
Zorin N.A., Zorina V.N. Rol' belkov semeistva makroglobulinov v mekhanizmakh infitsirovaniya. ZhMEI 2004; 3: 105-112.
Zorina V.N., Levchenko V.G., Zorina R.M. i dr. Assotsiirovannyi s beremennost'yu protein A, al'fa-2-makroglobulin, protein zony beremennosti i ikh kompleksy s IgG v syvorotke krovi zdorovykh neberemennykh i beremennykh zhenshchin i patsientok s rakom molochnoi zhelezy. Ros zhurn immunol 2001; 6: 71-76.
Kavetskii R.E. Mekhanizmy kantserogeneza i faktory antikantserogeneza. Vopr onkol 2005; 51: 6: 632-635.
Mal'tseva N.V., Zorin N.A. Sravnenie immunoregulyatornykh svoistv al'fa-2-makroglobulina i assotsiirovannogo s beremenennost'yu al'fa-2-glikoproteina. Ros zhurn immunol 1997; 2: 97-102.
Makhov V.A. Patogeneticheskoe znachenie ostrofazovykh belkov i provospalitel'nykh tsitokinov v diagnostike predrakovykh zabolevanii i raka gortani: Avtoref. dis. … kand. med. nauk. Novosibirsk 2004; 22.
Mingalev N.V. Klinicheskie i immunologicheskie osobennosti raka gortani v diagnostike, prognozirovanii techeniya zabolevaniya i vybore metoda lecheniya: Avtoref. dis. … d-ra med. nauk. M 1998; 44.
Promzeleva N.V. Prognosticheskaya znachimost' assotsiirovannogo s beremennost'yu al'fa-2-glikoproteina pri rake molochnoi zhelezy: Avtoref. dis. … kand. med. nauk. Tomsk 1998; 28.
Asplin I.R., Misra U.K., Gawdi G. et al. Selective upregulated expression of the alpha 2-macroglobulin signaling receptor in highly metastatic 1-Ln prostate carcinoma cells. Arch Biochem Biophys 2000; 383: 135-141.
Bode J.G., Fischer R., Haussinger D. et al. The inhibitory effect of IL-1 beta on IL-6-induced alpha 2-macroglobulin expression is due to activation of NF-kappa. Brit J Immunol 2001; 167: 1469-1481.
Birkenmeier G. Targeting the proteinase inhibitor and immune modulatory function of human alpha 2-macroglobulin. Mod Asp Immunobiol 2001; 3: 32-36.
Chiabrando G.A., Sanchez M.C., Skornicka E.L. et al. Low-density lipoprotein receptor-related protein mediates in PC 12 cell cultures the inhibition of nerve growth factor-promoted neurite outgrowth by pregnancy zone protein and alpha 2-macroglobulin. J Neurosci Res 2002; 70: 57-64.
Cianciolo G.J., Enhild J.J., Pizzo S. Covalent complexes of antigen and alpha 2-macroglobulin: evidence for dramatically-increased immunogenicity. Vaccine 2001; 20: 554-562.
Dajee M., Kazansky A.V., Raught B. Prolactin induction of the alpha 2-macroglobulin gene in the ovarian granulose cells: stat 5 activation and binding in the interleukin-6 response element. Med Endocrinol 1996; 10: 171-184.
Desser L., Holomanova D., Zavadova E. et al. Oral therapy with proteolytic enzymes decrease excessive TGF-beta levels in human blood. Cancer Chemother Pharmacol 2001; 47: Suppl 1: 10-15.
Foca C., Moses E.K., Quinn M.A. et al. Differential expression of the α2-macroglobulin receptor and receptor associated protein in normal human endometrium and endometrial carcinoma. Med Hum Reprod 2000; 6: 921-927.
Goulin-Charnet A., Laune D., Granier C. Alpha 2-macroglobulin, the main serum antiprotease, birth beta 2-microglobulin, the light chain of the class II major histocompatibility complex, which is involved in human disease. J Clin Sci 2000; 98: 427-433.
Hochepied T., Ameloot P., Bruckaert P. et al. Differential response of α2-macroglobulin-deficient mice in models of lethal TNF-induced inflammation. Eur Cytokine Netw 2000; 11: 597-601.
Hussaini L.M., Brown M.D., Karns L.R. et al. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes. Glia 1999; 25: 71-84.
Hibbets K., Hines B., Williams D. An overview of proteinase inhibitors. Br J Cancer 1999; 79: 244-250.
Ikari Y., Mulvihill E., Shwartz S.M. Alpha 1-proteinase inhibitor, alpha 1-antichumotrypsin, and α2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells. J Biol Chem 2001; 276: 11798-11803.
Isaac L., Florido M.P., Fecchio D. et al. Murine α2-macroglobulin increase during inflammatory responses and tumor growth. Inflamm Res 1999; 48: 446-452.
Kanoh Y., Ohtani N., Mashiko T. Levels of α2-macroglobulin can predict bone metastases in prostate cancer. Anticancer Res 2000; V: 551-556.
Kobayasi H., Carrasquillo J.A., Paik C.H. et al. Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15. Cancer Res 2000; 60: 3577-3583.
Kotiza J. Proteases and antiproteases in health and disease: a review. IV. Alpha-2-macroglobulin. Biomarkers Environ 2002; 5: 2-14.
Lee C.K., Piedrahita J.A. Inhibition of apoptosis in serum starved porcine embryonic fibro-blasts. Mol Reprod Dev 2002; 62: 106-112.
Liao H.X., Cianciolo G.J., Staats H.F. et al. Increased immunogenicity of HIV envelope subunits complexed with α2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF. Vaccine 2002; 20: 2396-2403.
Lin M., Sutheriand D.R., Horstall W. Cell surface antigen CD 109 is novel member of the alpha 2-macroglobulin, C3, C4, C5 family of thioester-contaning proteins. Blood 2002; 99: 1683-1691.
Ludwig T., Ossig R., Gressel S. et al. The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion. Am J Physiol 2002; 283: 319-327.
Misra U.K., Pizzo S.V. Regulation of cytosolic phospholipase A2 activity in macrophages stimulated with receptor-recognized form of α2-macroglobulin: role in mitogenesis and cell proliferation. J Biol Chem 2002; 277: 4069-4078.
Petersen S.M. Alpha-2-macroglobulin and pregnancy zone protein. Serum level, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology. Dan Med Bull 1993; 40: 409-446.
Maltseva N.V., Zorina R.M., Mingaljev N.V. et al. Tissue distribution of rat macroglobulin in tumor-bearing rats. Int J Exp Path 1999; 80: 105-108.
Wu S.M., Pizzo S.V. Mechanism of hypochlorite-mediated inactivation of proteinase inhibition by alpha 2-macroglobulin. Biochemistry 1999; 38: 13983-13990.
Yarovinsky T.O., Gorlina N.K., Zorin N.A. Immobilized alpha2-macroglobulin-plasmin as a factor of cell microenvironment Immunol. Letters 2000; 73: 253.
Zhang W.M., Finne P., Leinonen G. et al. Determination of proteinase - specific antigen complex to α2-macroglobulin in serum increases the specificity of free to total PSA for prostate cancer. Urology 2000; 56: 2: 267-272.